Redmile Group’s Astria Therapeutics ATXS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-269,078	Closed	-$1.44M	–	50
2025 Q1	$1.44M	Sell	269,078 -77,200	-22%	-$412K	0.14%	52
2024 Q4	$3.1M	Buy	346,278 +35,394	+11%	+$316K	0.22%	49
2024 Q3	$3.42M	Buy	+310,884	New	+$3.42M	0.2%	52